Hip Arthroscopy Postoperative Opioid Demands Study
This study is looking at different ways to manage pain after hip arthroscopy (a surgery to repair hip joint problems). It compares two pain management plans: one with a standard amount of Norco (hydrocodone-acetaminophen) pills, and another with fewer Norco pills combined with Tylenol (acetaminophen) and Gabapentin. The goal is to see if the reduced opioid plan can manage pain effectively while using fewer opioid medications. You might be able to join if you are between 18 and 80 years old, speak English, haven't taken opioid pills recently, and are having your first hip arthroscopy. The study will measure your pain scores at 1, 3, and 6 months after surgery to see which plan works best. The current status of this study is unclear.
- Study design
- This is a single-blinded, randomized controlled trial, meaning you won't know which pain management plan you receive. About 170 participants are planned for this study.
- What's involved
- You will be randomized to one of two pain management plans after your hip arthroscopy. Follow-up appointments will take place at 1, 3, 6, and 12 months after your surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Hip Arthroscopy Postoperative Opioid Demands
At a glance
Conditions
NCT04094701
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Rush University Medical Center
Chicago, Illinoisstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Pain Score1 month postoperatively
Visual Analog Scale: unidimensional measure of pain intensity, which has been widely used in diverse adult populations. Score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.
- Pain Score3 months postoperatively
Visual Analog Scale: unidimensional measure of pain intensity, which has been widely used in diverse adult populations. Score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.
- Pain Score6 months postoperatively
Visual Analog Scale: unidimensional measure of pain intensity, which has been widely used in diverse adult populations. Score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.
- Pain Score12 months postoperatively
Visual Analog Scale: unidimensional measure of pain intensity, which has been widely used in diverse adult populations. Score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.
- Total morphine equivalents takenIn the first 30 days after discharge
Standardized reporting of amount of opioids taken
- Number of unused opioid pillsIn the first 30 days after discharge
Pills not taken by patient
- Opioid disposal ratesIn the first 30 days after discharge
Number of unused pills properly disposed of